About

Armando Serao is a urologic surgeon and researcher whose work centers on advancing surgical outcomes for bladder and prostate cancers. His major contributions lie in large-scale, multi-institutional registry studies that provide real-world evidence for treatment decisions. He is a key contributor to the Italian Radical Cystectomy Registry (RIC), a prospective observational study that has enrolled over 1,400 patients, comparing robot-assisted, laparoscopic, and open radical cystectomy. This work, published in 2022 with 8 citations, offers critical pre-operative data to help standardize care for bladder cancer patients. More recently, Serao has tackled the challenge of interpreting PSMA-PET imaging for prostate cancer staging. In a 2025 prospective multicenter study, he assessed urologists’ ability to read these scans, highlighting a gap in specialist training and the need for standardized interpretation protocols. Though early in his career, Serao’s focus on collaborative, data-driven research—from surgical technique comparisons to imaging literacy—positions him as a rising voice in evidence-based urologic oncology, with implications for both clinical guidelines and patient outcomes.

Research Focus

Key Achievements

1
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 60
🏛 Institutions: Azienda Sanitaria Locale Alessandria, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago